Clinical Research & Development Business
Executive Vice President
Providing teams of only leaders and monitors trained to the highest internal standards
Linical specializes in the Phase II and Phase III processes of clinical trials with patients, which are considered particularly important in the R&D stage of new drug development. In these activities, we provide “monitoring”, a key element of successful clinical trials, as well as “quality control (QC)”, and “consulting”. We provide teams made up exclusively of leaders and monitors that have been trained to the highest standards directly by Linical, to ensure the collection of highly dependable data and to facilitate rapid, reliable new drug development.
Linical has specialized in areas of medicine in which drug development is notoriously difficult, such as oncology and central nervous system (CNS), so most of our monitors have experience working in large hospitals on new drug development in these areas. However, we are not satisfied to just assign experienced monitors; we implement team management centered around leaders who receive regular management training and quality control (QC) through specialized QC personnel. In this way, we can be sure to maintain the highest quality. In addition, ever since Linical was established, we have held monthly meetings in which all team leaders participate, to share and reflect on case studies of successful and challenging experiences. This process ensures that our high quality standards penetrate throughout all of our project teams.
Focusing efforts on speeding up the new drug development process
Linical focuses considerable effort on speeding up the new drug development process, to help accelerate time to market (TTM). In every phase of development, we actively propose measures to help our clients shorten the enrolment period, regardless of the period of contract with clients.
As a group of professionals in new drug development, we aim to be a true Clinical Development Partner to our clients.